Results 191 to 200 of about 32,390 (296)
Machine-Learning-Driven Phenotyping in Heart Failure with Preserved Ejection Fraction: Current Approaches and Future Directions. [PDF]
Potoupni V +9 more
europepmc +1 more source
The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials.
S. Oghina +8 more
semanticscholar +1 more source
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg +17 more
wiley +1 more source
Diagnostic and prognostic implications of growth differentiation factor 15 in heart failure with preserved ejection fraction: a systematic review and meta-analysis. [PDF]
Dakota I +11 more
europepmc +1 more source
The Possible Role of Rosuvastatin Therapy in HFpEF Patients—A Preliminary Report
Tomasz Urbanowicz +8 more
openalex +1 more source
Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates. [PDF]
Abdelhamid M +5 more
europepmc +1 more source
Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle
Monika Rech +4 more
openalex +2 more sources
Left Atrial Dysfunction in Patients with Atrial Fibrillation and Heart Failure. [PDF]
Trankle CR +5 more
europepmc +1 more source
ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura +23 more
wiley +1 more source

